GLP-1 market heats up as companies vie for next-gen obesity drugs
Oct 31, 2024 · Since the FDA approval of Novo Nordisk’s Wegovy as a treatment for chronic weight management in 2021, followed by the approval of Ozempic the next year, demand for …
Noema Pharma Secures $147M to Advance CNS Disorder …
Dec 12, 2024 · Noema Pharma has announced an extension of its series B financing round, bringing the total raised up to $147 million (CHF 130 million). The round extension has seen …
Symbiosis unveils expanded facility at CPHI Milan 2024
Oct 2, 2024 · The event provides a great platform for the company to present its newest addition—a 20,000 sq ft facility in Stirling, UK, which the company says enhances Symbiosis' …
Novo Nordisk signs $285 million deal for a once-monthly Wegovy
Nov 7, 2024 · Ascendis Pharma has granted Novo Nordisk an exclusive worldwide license to its TransCon technology platform for the development, manufacturing and commercialization of …
Vetter Pharma International
Vetter is a leading global contract development and manufacturing organization (CDMO) for the aseptic production of injectables. Our headquarters are in Ravensburg, Germany, where we …
How eCOA/ePRO is transforming clinical trials
Nov 25, 2024 · (Image: Getty/Spainter_vfx) Q: What trends do you see shaping eCOA/ePRO in the next year? SR: Personalization and adaptability are big ones.Patients want tailored …
AbbVie acquires Nimble for oral peptides
Dec 17, 2024 · “The talented, passionate and dedicated team at Nimble has made great progress over the past few years and we are pleased that AbbVie has recognized the tremendous …
NorthStar launches radiopharmaceutical CDMO
Oct 24, 2024 · The increasing integration of medical radioisotopes with diagnostic and molecular imaging as well as the rise of personalized medicine is spurring the growth of the global …
$680M deal with CBC and Mubadala shifts UCB's strategy
Aug 29, 2024 · The $680 million transaction, announced on August 26, involves the sale of established brands such as Keppra, Vimpat, Neupro, Zyrtec, and Xyzal, along with UCB's …
How will the Biosecure Act impact the pharma industry?
Oct 8, 2024 · But what does the Act mean for the biotech and pharma industry and how can companies best prepare for any impacts on future business? The Biosecure Act was first …